Iovance Biotherapeutics
IOVA
IOVA
227 hedge funds and large institutions have $1.25B invested in Iovance Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 64 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
12% more call options, than puts
Call options by funds: $6.36M | Put options by funds: $5.67M
5% more funds holding
Funds holding: 217 → 227 (+10)
18.11% less ownership
Funds ownership: 109.65% → 91.54% (-18%)
Holders
227
Holding in Top 10
2
Calls
$6.36M
Puts
$5.67M
Top Buyers
| 1 | +$53.8M | |
| 2 | +$32.8M | |
| 3 | +$16.7M | |
| 4 |
Morgan Stanley
New York
|
+$16.6M |
| 5 |
O
OrbiMed
New York
|
+$16.5M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$9.88M | |
| 3 | -$8.1M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$7.14M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6M |